Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide

Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…

Nitrosamines Analysis in Pharmaceuticals Using Triple Quadrupole LC/MS/MS and Quadrupole Time of Flight LC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N…

Application Note Pharma & Biopharma Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Lalith Hansoge, Vivek Dhyani, Samir Vyas, and Melissa Churley Agilent Technologies, Inc. Abstract This application note highlights…

CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…